These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11030639)

  • 1. Botulinum toxin for spastic gastrointestinal disorders.
    Hoogerwerf WA; Pasricha PJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Apr; 13(1):131-43. PubMed ID: 11030639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications and efficacy of botulinum toxin in disorders of the gastrointestinal tract.
    Mandal A; Robinson RJ
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):603-9. PubMed ID: 11396545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Using botulinum toxin type A in the gastrointestinal tract].
    Storr M; Allescher HD
    Med Klin (Munich); 2002 Jul; 97(7):396-401. PubMed ID: 12168477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Uses of Botulinum Toxin.
    Cariati M; Chiarello MM; Cannistra' M; Lerose MA; Brisinda G
    Handb Exp Pharmacol; 2021; 263():185-226. PubMed ID: 32072269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of botulinum toxin for the treatment of gastrointestinal motility disorders.
    Friedenberg F; Gollamudi S; Parkman HP
    Dig Dis Sci; 2004 Feb; 49(2):165-75. PubMed ID: 15104353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: botulinum toxin in the therapy of gastrointestinal motility disorders.
    Gui D; Rossi S; Runfola M; Magalini SC
    Aliment Pharmacol Ther; 2003 Jul; 18(1):1-16. PubMed ID: 12848622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms.
    Brisinda G; Bentivoglio AR; Maria G; Albanese A
    Mov Disord; 2004 Mar; 19 Suppl 8():S146-56. PubMed ID: 15027068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of botulinum toxin in gastrointestinal disorders].
    Zepeda-Gómez S; Valdovinos-Díaz MA
    Rev Gastroenterol Mex; 2002; 67(2):126-33. PubMed ID: 12214336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the use of botulinum toxin in the alimentary tract.
    Albanese A; Bentivoglio AR; Cassetta E; Viggiano A; Maria G; Gui D
    Aliment Pharmacol Ther; 1995 Dec; 9(6):599-604. PubMed ID: 8824646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Digestive tract and botulinum toxin].
    Gaudric M; Chaussade S
    Ann Readapt Med Phys; 2003 Jul; 46(6):353-60. PubMed ID: 12928143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.
    Vittal H; Pasricha PF
    Neurotox Res; 2006 Apr; 9(2-3):149-59. PubMed ID: 16785113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of gastrointestinal sphincters spasms with botulinum toxin A.
    Brisinda G; Sivestrini N; Bianco G; Maria G
    Toxins (Basel); 2015 May; 7(6):1882-916. PubMed ID: 26035487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up.
    Allescher HD; Storr M; Seige M; Gonzales-Donoso R; Ott R; Born P; Frimberger E; Weigert N; Stier A; Kurjak M; Rösch T; Classen M
    Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum.
    Wehrmann T; Kokabpick H; Jacobi V; Seifert H; Lembcke B; Caspary WF
    Endoscopy; 1999 Jun; 31(5):352-8. PubMed ID: 10433043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction.
    Pasricha PJ; Miskovsky EP; Kalloo AN
    Gut; 1994 Sep; 35(9):1319-21. PubMed ID: 7959245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia.
    Leyden JE; Moss AC; MacMathuna P
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005046. PubMed ID: 17054234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
    Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
    Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of botulinum toxin injections for treatment of esophageal motility disorders†.
    van Hoeij FB; Tack JF; Pandolfino JE; Sternbach JM; Roman S; Smout AJ; Bredenoord AJ
    Dis Esophagus; 2017 Feb; 30(3):1-5. PubMed ID: 27337985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases?
    Marjoux S; Brochard C; Roman S; Gincul R; Pagenault M; Ponchon T; Ropert A; Mion F
    Dis Esophagus; 2015; 28(8):735-41. PubMed ID: 25212219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal pharmacology and treatment of primary motility disorders.
    Storr M; Allescher HD
    Dis Esophagus; 1999; 12(4):241-57. PubMed ID: 10770358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.